FDA Adverse Event
Injury
Summary report: N
ULTRAFLOW HPC 1.5F
MDR report key: 2840723
·
Received November 20, 2012
Report
- Report Number
- 2029214-2012-00660
- Event Type
- Injury
- Date Received
- November 20, 2012
- Date of Event
- October 25, 2012
- Report Date
- October 26, 2012
- Manufacturer
- EV3 NEUROVASCULAR
- Product Code
- DYG
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
THE DEVICE INVOLVED IN THE EVENT HAS NOT BEEN RETURNED FOR EVALUATION.(B)(4).
Description of Event or Problem · 1
EMBOLIZATION TREATMENT OF AN AVM. DURING THE PROCEDURE, IT WAS REPORTED THAT THE CATHETER RUPTURED AFTER INJECTING 0.3ML OF ONYX 18.NO INJURY WAS REPORTED WITH THE PATIENT AS A RESULT OF THE PROCEDURE.SAME EVENT AS MDR# 2029214-2012-00661.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ULTRAFLOW HPC 1.5F | FLOW DIRECTED MICRO CATHETER | DYG | EV3 NEUROVASCULAR | 105-5065 | 9649259 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Disability |